Amylyx Pharmaceuticals, Inc.
AMLXNASDAQHealthcare● Active
$12.85
$-0.47(-3.52%)
Market Cap$1.1B
P/E Ratio—
52W High$18.605
52W Low$4.76
Amylyx Pharmaceuticals, Inc.（AMLX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · AMLX · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.09B | $0.38B | $0.02B | $0.00B |
| Cost of Revenue | $0.00B | $0.04B | $0.03B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | $0.05B | $0.36B | $0.02B | $0.00B |
| Gross Margin %(computed) | — | 51.75% | 93.32% | 86.54% | — |
| Operating Expenses | |||||
| R&D Expenses | $0.09B | $0.10B | $0.13B | $0.09B | $0.04B |
| G&A Expenses | $0.00B | $0.11B | $0.18B | $0.12B | $0.04B |
| Total Operating Expenses | $0.15B | $0.36B | $0.32B | $0.22B | $0.08B |
| Operating Income | ($0.15B) | ($0.31B) | $0.04B | ($0.20B) | ($0.08B) |
| Operating Margin %(computed) | — | -360.22% | 10.19% | -905.72% | — |
| Interest Income | $0.01B | $0.01B | $0.02B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.14B) | ($0.30B) | $0.05B | ($0.20B) | ($0.09B) |
| Income Tax Expense | $0.00B | ($0.00B) | $0.01B | $0.00B | $0.00B |
| Net Income | ($0.14B) | ($0.30B) | $0.05B | ($0.20B) | ($0.09B) |
| Net Margin %(computed) | — | -345.36% | 12.94% | -892.38% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.53 | $-4.43 | $0.73 | $-2.98 | $-1.52 |
| Wtd Avg Shares | 0.09B | 0.07B | 0.07B | 0.07B | 0.06B |
| EBITDA | ($0.14B) | ($0.29B) | $0.04B | ($0.20B) | ($0.08B) |
| EBITDA Margin %(computed) | — | -333.03% | 10.48% | -903.53% | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Amylyx Pharmaceuticals, Inc.
关于Amylyx Pharmaceuticals, Inc.（AMLX）损益表
Amylyx Pharmaceuticals, Inc.（AMLX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，AMLX实现营收$0.00B，毛利润($0.00B)（毛利率—），净利润($0.14B)（净利率—）。
常见问题
AMLX · 4 问Amylyx Pharmaceuticals, Inc.（AMLX）2025财年营收为$0.00B，同比down100.0%。
AMLX revenueAMLX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08